Viewing nowRivatin Tablet 20 mg (Atorvastatin Calcium Hydrate)
Atorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
PharmGen Science Co., Ltd.

MFDS item code 201309488 · Approved 2013.09.30 · Insurance code 670103460
Improvement of hyperlipidemia; prevention of cardiovascular diseases (including myocardial infarction and stroke)
This medication helps reduce the risk of cardiovascular diseases. It reduces the risk of myocardial infarction and stroke in adults with multiple risk factors for coronary heart disease or in patients with type 2 diabetes. Additionally, in patients who already have coronary heart disease, it lowers the risks associated with myocardial infarction, stroke, vascular surgeries, congestive heart failure, and angina. It also reduces total cholesterol and LDL-cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia while increasing HDL-cholesterol, thereby improving blood lipid levels. It serves as an effective adjunctive therapy for patients with dyslipidemia not controlled by diet. Moreover, it is used in children and adolescents aged 10 to 17 years with familial hypercholesterolemia to help lower cholesterol levels.
Before and during treatment with atorvastatin, patients should follow a standard cholesterol-lowering diet. The medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (40 mg is for patients requiring an LDL cholesterol reduction of 45% or more). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older patients: The efficacy and safety in patients aged 70 years or older are generally similar to those in the general adult patient population.
10 ~ 17 years: The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses greater than 20 mg in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goals for each patient. The dose should be adjusted at intervals of 4 weeks or longer.
This medication may cause muscle abnormalities, so patients should consult a doctor immediately if they experience muscle pain or weakness symptoms. For patients at a high risk of muscle damage, it may be necessary to temporarily suspend or discontinue this medication. Patients with poor liver function or a history of liver disease must consult a doctor before using this medication. Women who are pregnant or may become pregnant should not take this medication, and effective contraception should be used during treatment. It is also safe for breastfeeding women to avoid using this medication. Children, especially those under 10 years old, should not use this medication. Elderly patients or those with impaired kidney function should use it cautiously due to a higher risk of muscle abnormalities. This medication may interact with certain drugs, so patients taking other medications must inform their doctor or pharmacist. In case of overdose, there is no specific antidote, and appropriate treatment should be administered according to symptoms. Liver function and muscle condition should be regularly monitored. Store this medication out of reach of children and keep it in its original container for safety. If symptoms of hepatitis, skin rash, or allergic reactions such as hives occur during treatment, stop taking the medication immediately and inform medical staff. This medication can elevate blood sugar levels, so patients at risk of diabetes must carefully manage their blood glucose levels. If symptoms such as muscle pain, weakness, fatigue, fever, etc., appear, consult a doctor immediately and undergo tests.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a well-sealed container to prevent air or moisture ingress. It is important to maintain storage temperature between 1 to 30 degrees Celsius. This will help preserve the medication's effectiveness and safety for a longer duration.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
PharmGen Science Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.